ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 621,12
0,16%
Dow Jones
39 127,80
0,04%
DAX
18 221,13
0,32%
Brent Oil
84,805
0,40%
Bitcoin
60 781,86
-0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Genuit Group Plc (GEN)

  7. Genuit Group Plc (GEN) Actualités

GEN

Genuit (GEN)

Genuit Group Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:GEN
DateHeureSourceTitreSymboleSociété
10/06/202417h34RNS Regulatory NewsGenuit Group PLC Holding(s) in CompanyLSE:GENGenuit Group Plc
28/05/202415h14RNS Regulatory NewsGenuit Group PLC Result of AGMLSE:GENGenuit Group Plc
28/05/202411h44Alliance NewsAlliance NewsGenuit revenue falls due to weak housebuilding and wet weather in UKLSE:GENGenuit Group Plc
28/05/202408h00RNS Regulatory NewsGenuit Group PLC Trading UpdateLSE:GENGenuit Group Plc
14/05/202409h00PR Newswire (US)Deepfakes, AI-Manipulated Audio, and Hijacked Social Media Surge in 2024LSE:GENGenuit Group Plc
02/05/202417h57RNS Regulatory NewsGenuit Group PLC Block listing Interim ReviewLSE:GENGenuit Group Plc
24/04/202411h39RNS Regulatory NewsGenuit Group PLC Notice of AGMLSE:GENGenuit Group Plc
10/04/202417h24RNS Regulatory NewsGenuit Group PLC Director/PDMR ShareholdingLSE:GENGenuit Group Plc
09/04/202417h28RNS Regulatory NewsGenuit Group PLC Director DeclarationLSE:GENGenuit Group Plc
12/03/202411h40Alliance NewsAlliance NewsGenuit revenue drops on lower divisional sales but profit surgesLSE:GENGenuit Group Plc
12/03/202408h09Alliance NewsAlliance News*Genuit says 2024 trading has started in line w/ expectations, despite market uncertaintyLSE:GENGenuit Group Plc
12/03/202408h09Alliance NewsAlliance News*Genuit declares total dividend per share of 12.4p vs 12.3p YoYLSE:GENGenuit Group Plc
12/03/202408h07Alliance NewsAlliance News*Genuit 2023 pretax profit GBP48.4m vs GBP45.4m YoYLSE:GENGenuit Group Plc
12/03/202408h00RNS Regulatory NewsGenuit Group PLC Final ResultsLSE:GENGenuit Group Plc
19/02/202410h00RNS Regulatory NewsGenuit Group PLC Notice of Results and Investor PresentationLSE:GENGenuit Group Plc
23/01/202412h24UK RegulatoryGenmab A/S Genmab Announces Net Sales Of Darzalex(R) (daratumumab) For 2023LSE:GENGenuit Group Plc
23/01/202400h40UK RegulatoryGenmab A/S Genmab Announces Decision In Arbitration Appeal Under License Agreement With JanssenLSE:GENGenuit Group Plc
09/01/202412h45UK RegulatoryGenmab A/S Tivdak(R) (tisotumab vedotin-tftv) Supplemental Biologics License Application Accepted For Priority Review By U.S. Food And Drug Administration For Patients With Recurrent Or Metastatic Cervical CancerLSE:GENGenuit Group Plc
03/01/202406h55UK RegulatoryGenmab A/S Transactions With Shares And Linked Securities In Genmab A/S Made By Managerial Employees And Their Closely Associated PersonsLSE:GENGenuit Group Plc
02/01/202415h52UK RegulatoryGenmab A/S Genmab To Present At The 42nd Annual J.P. Morgan Healthcare ConferenceLSE:GENGenuit Group Plc
12/12/202313h00UK RegulatoryGenmab A/S Genmab To Hold 2023 R&D Update And Ash Data Review MeetingLSE:GENGenuit Group Plc
09/12/202318h00UK RegulatoryGenmab A/S New Pivotal Data For Bispecific Antibody Epcoritamab (DuoBody(R) Cd3xcd20) Demonstrates High Overall And Complete Responses In Patients With Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)LSE:GENGenuit Group Plc
05/12/202323h26UK RegulatoryGenmab A/S Capital Increase In Genmab As A Result Of Employee Warrant ExerciseLSE:GENGenuit Group Plc
27/11/202313h00UK RegulatoryGenmab A/S Genmab Announces Positive Regulatory Updates For Epcoritamab (EPKINLY(R)/Tepkinly(R)) For The Treatment Of Relapsed/Refractory Follicular LymphomaLSE:GENGenuit Group Plc
22/11/202308h00UK RegulatoryGenuit Group PLC Strategy Progress Update NotificationLSE:GENGenuit Group Plc
21/11/202322h42UK RegulatoryGenmab A/S Grant Of Restricted Stock Units To Board Members And Employees And Grant Of Warrants To Employees In GenmabLSE:GENGenuit Group Plc
15/11/202310h03Alliance NewsAlliance NewsGenuit shares rise as annual profit predicted to exceed expectationsLSE:GENGenuit Group Plc
09/11/202315h14UK RegulatoryGenmab A/S Major Shareholder AnnouncementLSE:GENGenuit Group Plc
09/11/202311h00UK RegulatoryGenmab A/S Genmab To Present At Jefferies London Healthcare ConferenceLSE:GENGenuit Group Plc
07/11/202317h01UK RegulatoryGenmab A/S Genmab Announces Financial Results For The First Nine Months Of 2023LSE:GENGenuit Group Plc
 Showing the most relevant articles for your search:LSE:GEN

Dernières Valeurs Consultées

EU
AI
Air Liquide
NYSE
NKE
Nike
EU
BEL20
Bel 20
NASDAQ
NVDA
NVIDIA
EU
DG
Vinci
NYSE
DIS
Walt Disney
EU
AF
Air FranceKLM
EU
EN
Bouygues
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
EU
ML
Michelin
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés